Vir Biotechnology has concluded subject enrolment for the Phase III Eclipse 1 trial assessing the efficacy and safety of ...
Many of the 14 Radical Cup championships from around the world concluded their 2025 seasons in recent weeks, but teams and ...
Vir Biotechnology, Inc. (($VIR)) announced an update on their ongoing clinical study. Vir Biotechnology, Inc. is conducting a Phase 1 study titled ...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the completion of enrollment for ECLIPSE 1, a Phase 3 trial evaluating the safety and efficacy of the combination of tobevibart and elebsiran in ...
Key Insights Significantly high institutional ownership implies Vir Biotechnology's stock price is sensitive to ...
In a recent gazette notification, the Centre has announced Vir Chakra, India’s third-highest wartime gallantry award, to six ...
Vir Das raised concerns about bursting firecrackers to celebrate Diwali and shared that he finds the reasoning ‘inexplicable’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback